Seladelpar Could 'Raise the Bar' in PBC Treatment
The investigational agent significantly improved liver biomarkers of disease activity and symptoms of pruritus in adults with PBC enrolled in a phase 3 trial.
Source: medscape.com
Fast, Ad-Free News Updates
Stay updated with breaking news from Davidn Assis. Real-time updates on events, politics, business and more.